Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Anti-coronavirus (SARS-CoV-2) spike S1, mouse, mAb, MP Biomedicals™

Catalog No. MP08720302 Shop All MP Biomedicals, Inc Products
Change view
Click to view available options
Quantity:
250 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
MP08720302 250 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. MP08720302 Supplier MP Biomedicals, Inc Supplier No. 08720302

Monoclonal antibody raised against the coronavirus spike S1 protein, a common target for neutralizing antibodies and vaccines.

Anti-coronavirus (SARS-CoV-2) spike S1, mouse, mAb. Its genome encodes four structural proteins, i.e. spike (S), envelope (E), membrane (M), and nucleocapsid (N). The spike protein (S-protein) contains two subunits, S1 and S2. S1 defines the range of the hosts and specificity of the virus, thus recognizes and binds with the cell surface receptor. S2 subunit contains basic elements needed for the membrane fusion. The spike protein is the common target for neutralizing antibodies and vaccines.

TRUSTED_SUSTAINABILITY

Specifications

Antigen Coronavirus Spike S1 Protein
Applications Western Blot, Immunoprecipitation
Classification Monoclonal
Conjugate Unconjugated
Host Species Mouse
Quantity 250 μg
Regulatory Status RUO
Primary or Secondary Primary
Target Species None
Isotype IgG1
WARNING: Cancer - www.P65Warnings.ca.gov

For research or further manufacturing use only, not for direct human use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.